UNAIDS welcomes South Africa’s Lenacapavir HIV prevention launch

Kiswahili

UNAIDS has welcomed South Africa’s rollout of Lenacapavir as a landmark step in HIV prevention. The injectable is now available at 360 public health facilities across six provinces. The drug has also been added to the national essential medicines list.

South Africa launched the Lenacapavir HIV prevention programme on 6 June 2026. UNAIDS described the development as a landmark achievement for the country. The injectable is currently available at 360 public health facilities in six provinces. Officials have added the drug to South Africa’s essential medicines list. UNAIDS highlighted the rollout as an important measure to expand access to effective HIV prevention options.

Makala yanayohusiana

South Africa begins lenacapavir rollout to cut HIV infections

South Africa has started rolling out the twice-yearly HIV prevention injection lenacapavir, though success depends on managing interactions with common tuberculosis medicines.

US Pepfar cuts continue to threaten lenacapavir rollout in South Africa

Imeripotiwa na AI

A new NGO report warns that lingering effects of 2025 US Pepfar funding cuts are undermining South Africa's rollout of the six-monthly HIV prevention injection lenacapavir, despite recent US funding restoration efforts and initial shipments. Community infrastructure losses hinder uptake among high-risk groups, even as rollout begins late May.

Afrika

Ethiopia gains international recognition for health sector capacity

Afrika

Novo Nordisk heads to South African court over semaglutide copies

Afrika

South africa rolls out unprecedented foot and mouth disease vaccination drive

South Africa assesses low risk from new Ebola outbreak

The World Health Organization has declared the Ebola outbreak in the Democratic Republic of the Congo and Uganda a public health emergency of international concern. South African health officials say the risk of spread to the country remains low but stress the need for continued vigilance.

CAR-T cell therapy shows early promise for HIV control

Imeripotiwa na AI

A small study has found that CAR-T cell therapy may offer a new way to manage HIV over the long term. The approach, already used to treat certain cancers, involves engineering a patient’s own immune cells.

Alhamisi, 16. Mwezi wa saba 2026, 01:52:57

Brazil completes technology transfer to produce dolutegravir

Jumamosi, 11. Mwezi wa saba 2026, 19:07:10

455,188 HIV medication bottles arrive in the Philippines

Jumamosi, 4. Mwezi wa saba 2026, 03:47:42

South Africa's BEAT Tuberculosis study improves drug-resistant TB treatment

Jumanne, 23. Mwezi wa sita 2026, 07:27:48

Ripoti ya NSDCC yaonyesha Wakenya 98,000 hawajui wana HIV

Jumamosi, 13. Mwezi wa sita 2026, 13:47:38

U.S. pledges Ksh6.5 billion for Ebola countermeasures

Jumatatu, 1. Mwezi wa sita 2026, 08:57:47

New HIV pill simplifies treatment for complex cases

Jumatatu, 25. Mwezi wa tano 2026, 16:22:53

Nadda chairs meeting on Ebola preparedness

Jumamosi, 2. Mwezi wa tano 2026, 23:24:40

Axel Kicillof announces boost in medication delivery in Buenos Aires

Tovuti hii inatumia vidakuzi

Tunatumia vidakuzi kwa uchambuzi ili kuboresha tovuti yetu. Soma sera ya faragha yetu kwa maelezo zaidi.
Kataa